trametinib,navitoclax,dabrafenib
novartis,abbvie
['trametinib', 'dabrafenib', 'melanoma', 'navitoclax']
live from #asco23: dr. zeynep eroglu presents her research on the randomized phase ii trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with braf-mutant (mt) metastatic melanoma (mm) (ctep p9466). learn more #asco23 
Moffitt Cancer Center is a global leader in patient care, research and education with a mission to contribute to the prevention and cure of cancer.